RxDoctor Payments DataLook up a doctor →

David Fried, MD

Internal Medicine · East Greenwich, RINPI 1275520678

Payments from drug & device makers

$37,160,858in general payments, 2019–2025

Across 5,164 payments — averaging $7196.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$10.5M
  • Modernatx, Inc.$6.4M
  • AstraZeneca$3.6M
  • Merck$2.9M
  • Seqirus USA Inc$1.6M
  • Vertex$1.5M
  • plus $10.7M from 30 others
$247,594in research payments, 2019–2025

Across 37 payments — averaging $6691.74 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$198K
  • Eli Lilly$49K

General payments by program year

21
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$37,160,858 in reported general payments places this provider in the 95th percentile of 808 internal medicine providers in Rhode Island.

See all internal medicine providers in Rhode Island

Medicare billing

Part B allowed, 2024
$54,404
Medicare patients
278
Services billed
776

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in East Greenwich

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →